Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PLETHORA SOLUTIONS LIMITED logo — Specializing in innovative solutions for urological health,...

PLETHORA SOLUTIONS LIMITED

Specializing in innovative solutions for urological health, addressing the unmet needs in this growing market.

Founded 2003 3 employees Post-IPO Equity Total: $5.00M Biotechnology, Pharmaceutical +1

General Information

Company Name PLETHORA SOLUTIONS LIMITED
Founded Year 2003
Employees 3
Industries Biotechnology, Pharmaceutical, Marketing
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with PLETHORA SOLUTIONS LIMITED. To contact PLETHORA SOLUTIONS LIMITED, visit plethorasolutions.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PLETHORA SOLUTIONS LIMITED compare?

A PDF of PLETHORA SOLUTIONS LIMITED and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PLETHORA SOLUTIONS LIMITED soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PLETHORA SOLUTIONS LIMITED

PLETHORA SOLUTIONS LIMITED is a specialty pharmaceutical company specializing in innovative solutions for urological health. Founded in 2003, the company focuses on developing and marketing products for the treatment and management of urological disorders in a market with significant unmet medical needs and commercial opportunities. Their main product, a treatment for male premature ejaculation, received marketing authorization from the European Commission on 19 November 2013. The last investment in Plethora Solutions was a $5.00M post-IPO equity investment by Crede CapitalGroup on 01 July 2014. This injection of capital demonstrates investor confidence in the company's potential to address unmet medical needs in the urological health market. As a player in the biotechnology, pharmaceutical, and marketing industries, Plethora Solutions holds promise in providing innovative solutions while catering to the growing demand in the urology sector.

Business keywords: Specialty pharmaceuticals, Urological health, Medical devices, Pharmaceutical products, Male premature ejaculation, European Commission, Marketing authorization, Business development, Investor relations, Commercial potential, Treatment and management, AIM: PLE, Diagnosis and treatment, Medical needs, European MAA

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $5.00M 1
Crede CapitalGroup
Crede CapitalGroup
01 Jul 2014
Seed Round Undisclosed 1
Excalibur Fund Managers
Excalibur Fund Managers
01 Jan 2004

PLETHORA SOLUTIONS LIMITED Alternatives & Competitors

View All Alternatives
PLETHORA SOLUTIONS LIMITED vs
Calliditas Therapeutics
Calliditas Therapeutics Sweden

Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the...

Post-IPO Debt
242 employees
Biotechnology, Medical Devices
PLETHORA SOLUTIONS LIMITED vs
Nevakar Inc.
Nevakar Inc. United States

Repositioning Drugs for a Better Outcome®

Private Equity
35 employees
Biopharma, Biotechnology
PLETHORA SOLUTIONS LIMITED vs
EUSA Pharma
EUSA Pharma United Kingdom

Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in the Recordati group...

Venture round
107 employees
Biotechnology, Health Care
View all alternatives

FAQ About PLETHORA SOLUTIONS LIMITED

Specializing in innovative solutions for urological health, addressing the unmet needs in this growing market.
PLETHORA SOLUTIONS LIMITED was founded in 2003.
PLETHORA SOLUTIONS LIMITED operates in Biotechnology, Pharmaceutical and Marketing. Its work centres on Specialty pharmaceuticals, Urological health, Medical devices and Pharmaceutical products.
PLETHORA SOLUTIONS LIMITED has approximately 3 employees.
PLETHORA SOLUTIONS LIMITED has completed 2 funding rounds, raising a total of $5.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to PLETHORA SOLUTIONS LIMITED include Calliditas Therapeutics, Nevakar Inc., EUSA Pharma, Cytochroma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PLETHORA SOLUTIONS LIMITED and Calliditas Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PLETHORA SOLUTIONS LIMITED, https://bouncewatch.com/company/plethora-solutions, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout